Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis
- PMID: 29934436
- DOI: 10.1136/gutjnl-2017-315340
Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis
Abstract
Objective: Faecal immunochemical tests (FITs) are replacing guaiac faecal occult blood tests (gFOBTs) for colorectal cancer (CRC) screening. Incidence of interval colorectal cancer (iCRC) following a negative stool test result is not yet known. We aimed to compare incidence of iCRC following a negative FIT or gFOBT.
Design: We searched Ovid Medline, Embase, Cochrane Library, Science Citation Index, PubMed and Google Scholar from inception to 12 December 2017 for citations related to CRC screening based on stool tests. We included studies on FIT or gFOBT iCRC in average-risk screening populations. Main outcome was pooled incidence rate of iCRCs per 100 000 person-years (p-y). Pooled incidence rates were obtained by fitting random-effect Poisson regression models.
Results: We identified 7 426 records and included 29 studies. Meta-analyses comprised data of 6 987 825 subjects with a negative test result, in whom 11 932 screen-detected CRCs and 5 548 gFOBT or FIT iCRCs were documented. Median faecal haemoglobin (Hb) positivity cut-off used was 20 (range 10-200) µg Hb/g faeces in the 17 studies that provided FIT results. Pooled incidence rates of iCRC following FIT and gFOBT were 20 (95% CI 14 to 29; I2=99%) and 34 (95% CI 20 to 57; I2=99%) per 100 000 p-y, respectively. Pooled incidence rate ratio of FIT versus gFOBT iCRC was 0.58 (95% CI 0.32 to 1.07; I2=99%) and 0.36 (95% CI 0.17 to 0.75; I2=10%) in sensitivity analysis. For every FIT iCRC, 2.6 screen-detected CRCs were found (ratio 1:2.6); for gFOBT, the ratio between iCRC and screen-detected CRC was 1:1.2. Age below 60 years and the third screening round were significantly associated with a lower iCRC rate.
Conclusion: A negative gFOBT result is associated with a higher iCRC incidence than a negative FIT. This supports the use of FIT over gFOBT as CRC screening tool.
Keywords: colorectal cancer screening; epidemiology; meta-analysis.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2. Cochrane Database Syst Rev. 2022. PMID: 35665911 Free PMC article. Review.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Gut. 2015. PMID: 26041750 Review.
-
Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.Br J Cancer. 2020 Mar;122(7):1109-1117. doi: 10.1038/s41416-020-0754-5. Epub 2020 Feb 18. Br J Cancer. 2020. PMID: 32066910 Free PMC article.
-
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330. Health Technol Assess. 2017. PMID: 28643629 Free PMC article. Review.
Cited by
-
FIT as a Comparator for Evaluating the Effectiveness of New Non-invasive CRC Screening Test.Dig Dis Sci. 2024 Nov 19. doi: 10.1007/s10620-024-08718-w. Online ahead of print. Dig Dis Sci. 2024. PMID: 39560807 Review.
-
Trends in colorectal cancer surgical resection rates during the screening era: a retrospective study in Italy.BMJ Open Gastroenterol. 2024 Aug 5;11(1):e001434. doi: 10.1136/bmjgast-2024-001434. BMJ Open Gastroenterol. 2024. PMID: 39106985 Free PMC article.
-
Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours.Cancers (Basel). 2024 Feb 13;16(4):769. doi: 10.3390/cancers16040769. Cancers (Basel). 2024. PMID: 38398160 Free PMC article.
-
Breath Fingerprint of Colorectal Cancer Patients Based on the Gas Chromatography-Mass Spectrometry Analysis.Int J Mol Sci. 2024 Jan 29;25(3):1632. doi: 10.3390/ijms25031632. Int J Mol Sci. 2024. PMID: 38338911 Free PMC article.
-
Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot.BMJ Open Gastroenterol. 2023 Nov 24;10(1):e001233. doi: 10.1136/bmjgast-2023-001233. BMJ Open Gastroenterol. 2023. PMID: 38007223 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical